These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 862726)

  • 1. Role of Friend-associated lymphatic leukemia virus in immunization against Friend leukemia complex.
    Bendinelli M
    Experientia; 1977 Apr; 33(4):455-6. PubMed ID: 862726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of some of the biological properties of Friend virus and its pseudotypes.
    Dawson PJ; Fieldsteel AH
    Int J Cancer; 1973 Mar; 11(2):484-93. PubMed ID: 4597858
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of in vitro antibody response by spleen cells of mice infected with Friend-associated lymphatic leukemia virus.
    Bendinelli M; Matteucci D; Toniolo A; Friedman H
    Infect Immun; 1979 Apr; 24(1):1-6. PubMed ID: 222677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous replication of Friend virus complex (spleen focus-forming virus-lymphatic leukemia-inducing virus) in mouse embryo fibroblasts. Retention of leukemogenicity and loss of immunosuppressive properties.
    Eckner RJ
    J Exp Med; 1975 Oct; 142(4):936-48. PubMed ID: 1176891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the role of lymphatic leukemia virus in the immunodepression exerted by Friend complex in leukaemia-resistant C57BL/6 mice.
    Bendinelli M; Campa M; Toniolo A; Garzelli C
    J Gen Virol; 1978 May; 39(2):243-51. PubMed ID: 565803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-surface antigens induced by Friend and Rauscher virus complexes and their associated lymphatic leukemia viruses in the rat.
    Kuzumaki N; Kobayashi H
    Cancer Res; 1975 Jul; 35(7):1718-22. PubMed ID: 1131829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protection of mice against Friend leukemia by active and passive immunization with isolated viral glycoprotein and its antiserum respectively (author's transl)].
    Hunsmann G; Moennig V; Seifert E; Schäfer W
    Z Naturforsch C Biosci; 1975; 30(2):309-10. PubMed ID: 125981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation immunity and the suppression of spleen colony formation by immunization with murine leukemia virus preparations (Friend).
    Friend C; Rossi GB
    Int J Cancer; 1968 Jul; 3(4):523-9. PubMed ID: 5682446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunotherapy of Friend leukemia with antiserum (author's transl)].
    Lynn TC; Metzgar RS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):94-104. PubMed ID: 7449527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of infection of mice with Friend leukemia complex viruses on background antibody-forming cell production in vitro.
    Bendinelli M; Matteucci D; Toniolo A; Friedman H
    Experientia; 1978 Sep; 34(9):1161-2. PubMed ID: 569071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous regression of Friend virus-induced erythroleukemia. II. regression of Friend murine leukemia virus-induced lymphocytic leukemia.
    Dietz M; Longley C; Fouchey SP; Hall L; Rich MA; Furmanski P
    J Natl Cancer Inst; 1977 Sep; 59(3):957-61. PubMed ID: 197250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible splenomegaly with low virus production induced in hyperimmune mice by parabiosis with Friend-virus-infected mice.
    Takizawa K; Yoshikura H; Sugano H; Yamamoto T
    Int J Cancer; 1973 Sep; 12(2):502-10. PubMed ID: 4799699
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic aspects of resistance to Friend leukemia virus.
    Franker CK; Quilligan JJ
    Proc Soc Exp Biol Med; 1966 Apr; 121(4):1090-3. PubMed ID: 5937708
    [No Abstract]   [Full Text] [Related]  

  • 14. Passive and active immunity to Friend virus disease.
    Mirand EA; Grace JT; Buffett RF
    Nature; 1966 Feb; 209(5024):696-8. PubMed ID: 5922129
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex.
    Steeves RA; Eckner RJ; Bennett M; Mirand EA; Trudel PJ
    J Natl Cancer Inst; 1971 Jun; 46(6):1209-17. PubMed ID: 4325930
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunodepression by Rowson-Parr virus in mice: effect of Rowson-Parr virus and Friend leukemia complex infections on contact sensitivity in susceptible and resistant mice.
    Bendinelli M; Campa M; Toniolo A
    Infect Immun; 1975 May; 11(5):1031-7. PubMed ID: 1123252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.
    Wahren B
    J Natl Cancer Inst; 1968 Oct; 41(4):931-8. PubMed ID: 5693664
    [No Abstract]   [Full Text] [Related]  

  • 18. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.
    Ruan KS; Lilly F
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study on the effects induced by an anemic strain of Friend leukemia virus in DBA/2 mice].
    Del Gobbo V; Santucci L; Premrov MG; Favalli C; Rinaldi C; Jezzi T; Titti F
    Boll Soc Ital Biol Sper; 1980 Sep; 56(18):1829-32. PubMed ID: 7195261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of immunization with nonviral antigens against Friend leukemia virus in mice.
    Nahon-Merlin E; Lacour F; Friend C; Revoltella R
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2018-21. PubMed ID: 287040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.